Literature DB >> 15177000

Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties.

Sutada Lotinun1, Glenda L Evans, James T Bronk, Mark E Bolander, Thomas J Wronski, Erik L Ritman, Russell T Turner.   

Abstract

UNLABELLED: We examined the time course effects of continuous PTH on cortical bone and mechanical properties. PTH increased cortical bone turnover and induced intracortical porosity with no deleterious effect on bone strength. Withdrawal of PTH increased maximum torque to failure and stiffness with no change in energy absorbed.
INTRODUCTION: The skeletal response of cortical bone to parathyroid hormone (PTH) is complex and species dependent. Intermittent administration of PTH to rats increases periosteal and endocortical bone formation but has no known effects on intracortical bone turnover. The effects of continuous PTH on cortical bone are not clearly established.
MATERIALS AND METHODS: Eighty-four 6-month-old female Sprague-Dawley rats were divided into three control, six PTH, and two PTH withdrawal (WD) groups. They were subcutaneously implanted with osmotic pumps loaded with vehicle or 40 microg/kg BW/day human PTH(1-34) for 1, 3, 5, 7, 14, and 28 days. After 7 days, PTH was withdrawn from two groups of animals for 7 (7d-PTH/7d-WD) and 21 days (7d-PTH/21d-WD). Histomorphometry was performed on periosteal and endocortical surfaces of the tibial diaphysis in all groups. microCT of tibias and mechanical testing by torsion of femora were performed on 28d-PTH and 7d-PTH/21d-WD animals. RESULTS AND
CONCLUSIONS: Continuous PTH increased periosteal and endocortical bone formation, endocortical osteoclast perimeter, and cortical porosity in a time-dependent manner, but did not change the mechanical properties of the femur, possibly because of addition of new bone onto periosteal and endocortical surfaces. Additionally, withdrawal of PTH restored normal cortical porosity and increased maximum torque to failure and stiffness. We conclude that continuous administration of PTH increased cortical porosity in rats without having a detrimental effect on bone mechanical properties.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177000     DOI: 10.1359/JBMR.040404

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

1.  The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.

Authors:  Yingben Xue; Yongjun Xiao; Jingning Liu; Andrew C Karaplis; Martin R Pollak; Edward M Brown; Dengshun Miao; David Goltzman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

2.  Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation.

Authors:  Makoto Okazaki; Sebastien Ferrandon; Jean-Pierre Vilardaga; Mary L Bouxsein; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

3.  Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts.

Authors:  Estelle N Bianchi; Serge L Ferrari
Journal:  Bone       Date:  2009-06-25       Impact factor: 4.398

4.  Comparative high-resolution pQCT analysis of femoral neck indicates different bone mass distribution in osteoporosis and osteoarthritis.

Authors:  A Rubinacci; D Tresoldi; E Scalco; I Villa; F Adorni; G L Moro; G F Fraschini; G Rizzo
Journal:  Osteoporos Int       Date:  2011-09-24       Impact factor: 4.507

5.  Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone.

Authors:  Masaya Etoh; Akira Yamaguchi
Journal:  J Bone Miner Metab       Date:  2010-11       Impact factor: 2.626

6.  The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.

Authors:  Teruyo Nakatani; Tiffany Chen; Joshua Johnson; Jennifer J Westendorf; Nicola C Partridge
Journal:  J Bone Miner Res       Date:  2018-04-25       Impact factor: 6.741

7.  Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.

Authors:  Hesham Tawfeek; Brahmchetna Bedi; Jau-Yi Li; Jonathan Adams; Tatsuya Kobayashi; M Neale Weitzmann; Henry M Kronenberg; Roberto Pacifici
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

8.  Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

Authors:  Masanobu Ohishi; Riccardo Chiusaroli; Michael Ominsky; Frank Asuncion; Clare Thomas; Richa Khatri; Paul Kostenuik; Ernestina Schipani
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

9.  Distinctive tooth-extraction socket healing: bisphosphonate versus parathyroid hormone therapy.

Authors:  Shinichiro Kuroshima; Rodan B Mecano; Ryuichiro Tanoue; Kiyono Koi; Junro Yamashita
Journal:  J Periodontol       Date:  2013-05-20       Impact factor: 6.993

10.  T cells potentiate PTH-induced cortical bone loss through CD40L signaling.

Authors:  Yuhao Gao; Xiaojun Wu; Masakazu Terauchi; Jau-Yi Li; Francesco Grassi; Sarah Galley; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.